Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-25-000123
Filing Date
2025-04-30
Accepted
2025-04-30 15:56:17
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS, INC. 10-Q 3-31-2025 form10q.htm   iXBRL 10-Q 1531497
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 27770
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 903681
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 12910
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 12807
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 7028
  Complete submission text file 0000874015-25-000123.txt   8274083

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ions-20250331.xsd EX-101.SCH 49363
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20250331_cal.xml EX-101.CAL 87757
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20250331_def.xml EX-101.DEF 241415
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20250331_lab.xml EX-101.LAB 699235
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20250331_pre.xml EX-101.PRE 358455
70 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1147905
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 25894677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)